Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.55% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1551
Zeta Global
ZETA
$8.13B
| $45.6M | 0.01% |
2,864,071
+1,234,412
| +76% | +$22.9M |
2024 Q3
6 quarters
|
|
1552
American Public Education
APEI
$794M
| $45.5M | 0.01% |
799,175
-48,145
| -6% | -$2.21M |
2013 Q2
51 quarters
|
|
1553
First Mid Bancshares
FMBH
$1.31B
| $45.4M | 0.01% |
1,101,095
+56,997
| +5% | +$2.36M |
2016 Q4
37 quarters
|
|
1554
ADMA Biologics
ADMA
$2.22B
| $45.1M | 0.01% |
5,005,481
+169,843
| +4% | +$2.68M |
2021 Q1
20 quarters
|
|
1555
First Financial Corp
THFF
$880M
| $45M | 0.01% |
712,352
+3,870
| +0.5% | +$246K |
2013 Q2
51 quarters
|
|
1556
Astronics
ATRO
$2.94B
| $45M | 0.01% |
808,512
+40,822
| +5% | +$2.46M |
2013 Q2
51 quarters
|
|
1557
British American Tobacco
BTI
$114B
| $44.6M | 0.01% |
762,785
+5,155
| +0.7% | +$305K |
2013 Q2
51 quarters
|
|
1558
Healthcare Services Group
HCSG
$1.41B
| $44.5M | 0.01% |
2,400,681
+62,689
| +3% | +$1.24M |
2013 Q2
51 quarters
|
|
1559
Colliers International
CIGI
$4.67B
| $44.5M | 0.01% |
416,549
+54,695
| +15% | +$6.82M |
2013 Q2
51 quarters
|
|
1560
IDEAYA Biosciences
IDYA
$3.65B
| $44.4M | 0.01% |
1,333,478
+394,621
| +42% | +$13.2M |
2021 Q3
18 quarters
|
|
1561
Oppenheimer Holdings
OPY
$1.28B
| $44.3M | 0.01% |
497,033
+7,384
| +2% | +$618K |
2013 Q2
51 quarters
|
|
1562
Brookfield Infrastructure
BIPC
$4.42B
| $44.2M | 0.01% |
1,118,467
+83,626
| +8% | +$3.84M |
2021 Q3
18 quarters
|
|
1563
RH
RH
$2.28B
| $44.2M | 0.01% |
316,111
+78,782
| +33% | +$14.4M |
2014 Q2
47 quarters
|
|
1564
Evertec
EVTC
$1.64B
| $44.2M | 0.01% |
1,566,018
-8,363
| -0.5% | -$238K |
2017 Q4
33 quarters
|
|
1565
CGI
GIB
$14.7B
| $44.1M | 0.01% |
603,911
-95,616
| -14% | -$7.64M |
2013 Q2
51 quarters
|
|
|
MCW
1566
DELISTED
Mister Car Wash
MCW
| $44.1M | 0.01% |
6,329,999
-277,393
| -4% | -$1.78M |
2023 Q3
10 quarters
|
|
1567
Universal Insurance Holdings
UVE
$1.2B
| $44.1M | 0.01% |
1,291,052
-13,439
| -1% | -$433K |
2013 Q2
51 quarters
|
|
1568
Dave Inc
DAVE
$4.33B
| $44.1M | 0.01% |
253,173
+42,262
| +20% | +$8.21M |
2024 Q4
5 quarters
|
|
1569
ManpowerGroup
MAN
$2.62B
| $44M | 0.01% |
1,492,467
-300,221
| -17% | -$8.92M |
2013 Q2
51 quarters
|
|
1570
Bath & Body Works
BBWI
$3.31B
| $43.8M | 0.01% |
2,344,717
-291,925
| -11% | -$6.31M |
2013 Q2
51 quarters
|
|
|
GOLD
1571
Gold.com Inc
GOLD
$1.23B
| $43.6M | 0.01% |
1,088,754
-94,040
| -8% | -$4.6M |
2014 Q2
47 quarters
|
|
1572
CNB Financial Corp
CCNE
$998M
| $43.6M | 0.01% |
1,505,993
+27,236
| +2% | +$761K |
2013 Q2
51 quarters
|
|
1573
Great Southern Bancorp
GSBC
$851M
| $43.6M | 0.01% |
690,092
+238
| +0% | +$14.9K |
2013 Q2
51 quarters
|
|
1574
Azenta
AZTA
$1.51B
| $43.5M | 0.01% |
2,060,322
-39,119
| -2% | -$1.17M |
2013 Q2
51 quarters
|
|
1575
10x Genomics
TXG
$11.6B
| $43.4M | 0.01% |
2,042,950
+525,369
| +35% | +$10.5M |
2020 Q3
22 quarters
|
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.